Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about O-GlcNAcylation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| Specificity Protein 1 | modulates | protein | 0.87 |
| GABARAPL1 | regulates | gene | 0.85 |
| AMPK | inhibits | protein | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| 41478829 | competes with | paper | 0.90 |
| Glucosamine | involved_in | compound | 0.85 |
| PRPS1 R196W | associated_with | protein | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| O-GlcNAcylation at T212 competes with phosphorylation to red | 0.000 | Alzheimer's disease and related tauopathies | How can ESCRT or SNARE targeting achieve |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.484
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning O-GlcNAcylation in their description or question text
No additional research found